Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
300386 Feitian Technologies
- 17.97
- -0.73-3.90%
Market Closed Dec 11 15:00 CST
7.51BMarket Cap-88.52P/E (TTM)
18.68High17.82Low337.03KlotVolume18.20Open18.70Pre Close609.83MTurnover13.58%Turnover RatioLossP/E (Static)418.04MShares22.0052wk High4.93P/B4.46BFloat Cap5.3252wk Low22.44Limit Up248.22MShs Float55.15Historical High14.96Limit Down4.60%Amplitude5.32Historical Low--Dividend TTM18.09Avg Price175.83KlotAsk--Div YieldTTM100Lot Size148.28KlotBid
Feitian Technologies Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 10.82%228.35M | -14.65%214.37M | -36.39%214.49M | -26.20%313.38M | -52.88%206.06M | -43.78%251.15M | -44.04%337.19M | -41.04%424.66M | -37.73%437.35M | 20.52%446.71M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.47%164.61K | -99.87%153.61K | -99.91%305.14K |
| Notes receivable and accounts receivable | -9.18%112.98M | 24.70%123.49M | -5.34%109.55M | 1.19%98.38M | -18.40%124.4M | -45.51%99.03M | -11.35%115.74M | -0.18%97.22M | -9.81%152.46M | 19.96%181.74M |
| -Notes receivable | 194.54%5.72M | 519.97%8.16M | 0.69%6.5M | -0.68%5.62M | 1,559.50%1.94M | -75.38%1.32M | 815.14%6.46M | 19.99%5.66M | -95.03%117K | 337.29%5.35M |
| -Accounts receivable | -12.41%107.26M | 18.03%115.33M | -5.70%103.05M | 1.31%92.76M | -19.61%122.46M | -44.61%97.71M | -15.84%109.28M | -1.20%91.57M | -8.61%152.34M | 17.37%176.4M |
| Other receivables (including interest and dividends) | -10.81%9.95M | -14.75%9.84M | -16.54%9.89M | -6.91%10.74M | -36.77%11.16M | -49.54%11.55M | -43.06%11.85M | 24.37%11.54M | 157.97%17.64M | 218.01%22.88M |
| -Other receivable | ---- | -14.75%9.84M | ---- | ---- | ---- | -49.54%11.55M | ---- | 24.37%11.54M | ---- | 218.01%22.88M |
| Advance payment | -51.84%21.89M | -40.94%25.04M | -40.13%37.88M | -51.01%30.83M | -46.06%45.46M | -53.74%42.4M | 0.03%63.28M | 88.89%62.94M | 115.71%84.29M | 107.20%91.65M |
| Inventories | -14.02%261M | -17.87%271.73M | -22.02%280.73M | -22.21%271.88M | -28.69%303.56M | -21.93%330.85M | -6.37%359.99M | 7.32%349.48M | 6.46%425.7M | -4.15%423.79M |
| Assets held for sale | --35.85M | --35.85M | --35.85M | --35.85M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 16.76%389.42M | 13.12%346.52M | 62.62%349.72M | 149.59%313.41M | 260.00%333.51M | 68.78%306.33M | 27.02%215.06M | -25.24%125.57M | 863.76%92.64M | 66.98%181.5M |
| Total current assets | 3.45%1.06B | -1.39%1.03B | -5.89%1.04B | 0.27%1.07B | -15.38%1.02B | -22.79%1.04B | -19.57%1.1B | -20.89%1.07B | -16.44%1.21B | -8.41%1.35B |
| Non Current assets | ||||||||||
| Other equity investment | 28.93%12.63M | 58.32%11.8M | 46.73%10.54M | 41.52%8.94M | 112.63%9.8M | 28.56%7.45M | 8.05%7.18M | -6.12%6.32M | -42.83%4.61M | -35.77%5.8M |
| Long-term equity investment | -91.15%3.33M | -89.57%4.05M | -91.44%3.47M | -92.04%3.5M | -14.87%37.66M | -11.61%38.82M | -13.45%40.57M | -6.54%43.95M | -5.35%44.24M | -5.25%43.92M |
| Fixed assets | ---- | -8.85%15.86M | ---- | ---- | ---- | 34.69%17.4M | ---- | 18.69%16.69M | ---- | -7.17%12.92M |
| Constru in process | ---- | 26.61%1.32M | ---- | ---- | ---- | -7.01%1.05M | ---- | 36.46%1.19M | ---- | 7.28%1.12M |
| Intangible assets | -36.38%4.86M | -34.97%5.51M | -33.64%6.17M | -32.24%6.85M | -30.05%7.65M | -27.83%8.48M | -26.27%9.29M | -24.90%10.11M | -21.47%10.93M | -20.68%11.75M |
| Goodwill | -23.17%70.24M | -23.17%70.24M | -23.17%70.24M | -23.17%70.24M | -10.64%91.41M | -10.64%91.41M | -10.64%91.41M | -10.64%91.41M | 0.00%102.29M | 0.00%102.29M |
| Long deferred expense | -25.39%2.76M | -24.92%3.02M | -42.98%3.24M | -42.98%3.61M | -45.34%3.71M | -20.77%4.03M | 5.46%5.68M | 11.30%6.33M | 16.70%6.78M | -16.59%5.08M |
| Deferred tax assets | -99.79%27.74K | -99.71%32.96K | -99.70%25.39K | -97.29%183.52K | -70.34%13.16M | -68.07%11.27M | -69.36%8.37M | -70.99%6.78M | 138.75%44.37M | 171.77%35.29M |
| Usufruct assets | -5.20%17.2M | -10.87%19.68M | -52.45%12.04M | -42.59%16.55M | -38.10%18.15M | -32.23%22.08M | -5.56%25.33M | 0.44%28.82M | 49.57%29.32M | 52.81%32.57M |
| Other non current assets | -6.92%499.74M | 2.99%548.84M | 3.02%544.87M | -10.86%540.9M | -3.16%536.88M | 19.07%532.89M | 18.66%528.92M | 37.28%606.77M | 64.48%554.43M | 33.96%447.53M |
| Total non current assets | -14.79%626.94M | -7.42%680.36M | -9.24%666.12M | -18.46%667.32M | -9.57%735.78M | 5.24%734.88M | 6.69%733.91M | 19.61%818.37M | 43.43%813.68M | 24.26%698.28M |
| Total assets | -4.18%1.69B | -3.88%1.71B | -7.23%1.7B | -7.84%1.74B | -13.04%1.76B | -13.22%1.78B | -10.80%1.84B | -7.30%1.89B | 0.41%2.02B | 0.62%2.05B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | -10.34%53.2M | 35.54%66.66M | 7.54%67.5M | 47.36%81.07M | -50.51%59.33M | -60.76%49.18M | -49.06%62.76M | -30.23%55.01M | 84.26%119.9M | 83.63%125.35M |
| -Accounts payable | -10.34%53.2M | 35.54%66.66M | 7.54%67.5M | 47.36%81.07M | -50.51%59.33M | -60.76%49.18M | -49.06%62.76M | -30.23%55.01M | 84.26%119.9M | 83.63%125.35M |
| Contract liabilities | 35.87%30.99M | 31.74%28.47M | 39.90%33.87M | 53.11%44.3M | -38.95%22.81M | -49.17%21.61M | -47.08%24.21M | -41.43%28.93M | -10.71%37.36M | -21.46%42.52M |
| Advance receipts | --31M | --31M | --15M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | -46.08%14.89M | -35.42%15.02M | -19.48%18.28M | 0.50%21.98M | 2.44%27.62M | 28.04%23.25M | 1.85%22.7M | -12.20%21.87M | 3.34%26.96M | 7.00%18.16M |
| Taxs payable | -46.62%2.39M | -15.01%2.62M | -12.90%2.22M | -39.64%3.94M | -4.66%4.48M | -5.59%3.08M | -7.97%2.55M | -26.78%6.53M | -27.30%4.7M | -6.74%3.27M |
| Other payable (including interest and dividends) | -45.23%193.52K | 3.13%185.47K | 102.51%408.21K | -45.64%2.5M | 2.88%353.36K | -53.13%179.84K | -29.76%201.57K | 76.99%4.6M | 161.21%343.46K | 26.45%383.7K |
| -Other payable | ---- | 3.13%185.47K | ---- | ---- | ---- | -53.13%179.84K | ---- | 76.99%4.6M | ---- | 27.59%383.7K |
| Non current liabilities due within one year | 19.97%10.49M | -6.47%10.36M | -59.54%5.2M | -43.96%7.41M | -26.64%8.74M | -10.26%11.07M | 12.62%12.86M | 19.99%13.23M | --11.92M | --12.34M |
| Other current liabilities | -20.39%1.84M | -12.35%1.92M | -66.44%2.21M | -76.65%2.56M | -40.57%2.31M | -38.32%2.19M | 84.50%6.59M | 132.69%10.98M | 1.01%3.89M | -25.50%3.55M |
| Total current liabilities | 15.40%145M | 41.29%156.23M | 9.71%144.7M | 23.10%173.76M | -38.73%125.66M | -46.21%110.57M | -36.99%131.89M | -21.76%141.15M | 42.95%205.08M | 38.95%205.56M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 32.99%5.91M | 63.49%6.05M | 99.75%5.99M | -26.53%5.32M | -29.49%4.44M | -34.46%3.7M | -42.47%3M | 59.05%7.24M | 70.64%6.3M | 57.27%5.65M |
| Long term deferred income | -81.34%1.54M | -79.53%1.7M | -17.82%6.88M | -31.98%5.73M | 110.48%8.27M | 109.00%8.32M | 107.56%8.38M | 106.15%8.43M | -0.04%3.93M | -5.70%3.98M |
| Lease liabilities | -36.93%6.29M | -22.62%8.84M | -50.84%6.3M | -39.98%9.58M | -43.55%9.98M | -43.53%11.42M | -17.27%12.81M | -9.19%15.95M | -11.26%17.67M | -5.50%20.22M |
| Total non current liabilities | -39.42%13.75M | -29.22%16.59M | -20.74%19.16M | -34.77%20.63M | -18.69%22.69M | -21.47%23.44M | -2.20%24.18M | 20.66%31.63M | 1.33%27.91M | 2.19%29.85M |
| Total liabilities | 7.01%158.75M | 28.96%172.83M | 5.00%163.86M | 12.51%194.39M | -36.33%148.35M | -43.07%134.02M | -33.32%156.07M | -16.38%172.78M | 36.25%232.99M | 32.89%235.42M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M | 0.00%418.04M |
| Capital reserve funds | -0.00%356.17M | -0.00%356.17M | -0.01%356.17M | -0.01%356.17M | -0.01%356.17M | -0.01%356.17M | 0.00%356.2M | 3.34%356.2M | 3.34%356.2M | 3.34%356.2M |
| Surplus reserve funds | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M | 0.00%118.35M |
| Retained profit | -11.90%626.86M | -14.88%633.31M | -18.40%640.72M | -20.92%649.4M | -20.49%711.57M | -19.01%744M | -16.07%785.23M | -12.83%821.18M | -6.06%894.99M | -4.79%918.69M |
| Other composite income | 48.79%3.7M | 541.21%3.9M | 168.00%2.41M | 118.68%620.58K | 172.00%2.49M | 109.20%608.13K | 63.19%-3.54M | 64.03%-3.32M | 48.83%-3.45M | -9.90%-6.61M |
| Shareholders equity without minority interests | -5.20%1.52B | -6.56%1.53B | -8.28%1.54B | -9.81%1.54B | -9.95%1.61B | -9.28%1.64B | -7.93%1.67B | -5.70%1.71B | -2.35%1.78B | -1.92%1.8B |
| Minority interests | -9.16%4.51M | -7.76%4.61M | -29.86%4.68M | -28.20%4.82M | -27.14%4.97M | -26.46%4.99M | -2.57%6.67M | -63.27%6.72M | -61.17%6.82M | -60.49%6.79M |
| Total shareholder equity | -5.21%1.53B | -6.56%1.53B | -8.36%1.54B | -9.89%1.55B | -10.01%1.61B | -9.35%1.64B | -7.91%1.68B | -6.28%1.72B | -2.91%1.79B | -2.46%1.81B |
| Total liabilityies and equity | -4.18%1.69B | -3.88%1.71B | -7.23%1.7B | -7.84%1.74B | -13.04%1.76B | -13.22%1.78B | -10.80%1.84B | -7.30%1.89B | 0.41%2.02B | 0.62%2.05B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
